TERF2 and breast cancer: Finally, by stratifying patients from TCGA dataset on the basis of the TRF2 mRNA expression (TRF2 low 314/599; TRF2 high 285/599), we found that high levels of TRF2 correlate with a worse clinical outcome of BC patients also by excluding stage IV patients (Fig. 5E, F).